1,672
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: CLINICAL ONCOLOGY

Are older patients with non-small cell lung cancer receiving optimal care? A population-based study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 309-317 | Received 01 Feb 2021, Accepted 26 Oct 2021, Published online: 14 Nov 2021

Figures & data

Table 1. Demographic and clinical characteristics of patients diagnosed with non-small cell lung cancer in Sweden 2002–2016 by age groups.

Table 2. Diagnostic intensity and multidisciplinary team assessment in patients diagnosed with non-small cell lung cancer in Sweden 2002–2016 by age groups.a

Table 3. Treatment modality in patients diagnosed with non-small cell lung cancer in Sweden 2002–2016 with performance status 0–2 by age groups and stage at diagnosis.a

Table 4. Mortality following start of treatment in IA-IIIA NSCLC patients diagnosed 2012–2016.

Figure 1. Cumulative overall and cause-specific survival in patients with non-small cell lung cancer and performance status 0–2 diagnosed in Sweden 2002–2016, by age group and stage at diagnosis.

Figure 1. Cumulative overall and cause-specific survival in patients with non-small cell lung cancer and performance status 0–2 diagnosed in Sweden 2002–2016, by age group and stage at diagnosis.

Figure 2. Cumulative cause-specific survival in patients diagnosed with non-small cell lung cancer stage IIIB–IV in Sweden 2002–2016 with performance status 0–2 receiving chemotherapy or other systemic therapies, by age group.

Figure 2. Cumulative cause-specific survival in patients diagnosed with non-small cell lung cancer stage IIIB–IV in Sweden 2002–2016 with performance status 0–2 receiving chemotherapy or other systemic therapies, by age group.